A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy
Title:
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy
Author:
Sculier, J.P. Berghmans, T. Lafitte, J.J. Richez, M. Recloux, P. Van Cutsem, O. Ninane, V. Mommen, P. Paesmans, M. Klastersky, J.